Biosimilars vs Generics

Biosimilars are not the same as generic therapies. The term “generic” has a precise meaning when it comes to medications – it is limited to small-molecule medications made from synthesized chemicals with a fixed number of atoms and a known chemical structure. A generic must be chemically identical to its branded counterpart and contain the same active ingredients. Biosimilars are much larger molecules derived from living cells, making them challenging to develop and manufacture. A biosimilar also must demonstrate no clinically meaningful differences in efficacy, safety, and potency with its reference product

  • Biosimilars Vs Generics: Similar but Not the Same
  • Differences Between Biosimilars and Generic Drugs
  • Inside biosimilar drug development
  • Critical quality attributes (CQAs)
  • Quality clone creation
  • Customizing the biosimilar development process
Submit Abstract